528例卡瑞利珠单抗治疗的免疫相关不良反应及风险因素分析
余敏, 李歆
Immunerelated adverse events and risk factors of carrelizumab in 528 cases of cancer patients
YU Min, LI Xin
中国药物警戒 . 2023, (10): 1134 -1140 .  DOI: 10.19803/j.1672-8629.20230011